{"id":70799,"date":"2026-05-12T11:37:16","date_gmt":"2026-05-12T11:37:16","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70799"},"modified":"2026-10-15T10:33:57","modified_gmt":"2026-10-15T10:33:57","slug":"glow","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-pt\/product\/glow\/","title":{"rendered":"GLOW Blend (BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg)"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Resposta R\u00e1pida \u2014 O que \u00e9 GLOW?<\/h3>\n<p style=\"margin: 0;\"><strong>GLOW<\/strong> \u00e9 uma mistura coformulada de tr\u00eas pept\u00eddeos que combina <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a> 10\u00a0mg, <a href=\"https:\/\/medsbase.com\/pt-pt\/ghk-cu\/\">GHK-Cu<\/a> 50\u00a0mg e <a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500\/\">TB-500<\/a> 10\u00a0mg in a single lyophilized vial. The combination covers three complementary regenerative mechanisms in one administration: BPC-157&#8217;s local angiogenic and growth-factor signalling, GHK-Cu&#8217;s copper-mediated dermal remodelling, and TB-500&#8217;s systemic G-actin-binding tissue migration. Each vial contains 70\u00a0mg of total peptide for clinical studies use only.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-pt\/reviews\/\">de clientes<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada encomenda est\u00e1 coberta pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Garantia de Reenvio<\/strong><\/a> \u2014 se a sua encomenda n\u00e3o chegar no prazo de 20 dias \u00fateis, reenviamo-la.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Composi\u00e7\u00e3o<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">BPC-157 10\u00a0mg + GHK-Cu 50\u00a0mg + TB-500 10\u00a0mg por frasco (propor\u00e7\u00e3o de massa 1:5:1, coformulado)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pept\u00eddeo Total por Frasco<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">70\u00a0mg de massa total de pept\u00eddeo<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00fameros CAS dos Componentes<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">137525-51-0 (BPC-157) \/ 49557-75-7 (GHK-Cu) \/ 77591-33-4 (TB-500 \/ timosina beta-4)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Perfil de Mecanismo<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Angiog\u00e9nese mediada por VEGF (BPC-157) + remodela\u00e7\u00e3o d\u00e9rmica mediada por cobre (GHK-Cu) + migra\u00e7\u00e3o tecidual sist\u00e9mica ligada \u00e0 G-actina (TB-500) \u2014 tr\u00eas vias regenerativas complementares<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">P\u00f3 coformulado liofilizado (tom azul claro devido ao Cu ligado)<sup>2+<\/sup>)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (cada componente verificado por HPLC, COA mediante pedido)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizado: 2\u20138 \u00b0C (frigor\u00edfico) para stock de trabalho; \u221220 \u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. Reconstitu\u00eddo: 2\u20138 \u00b0C, utilizar no prazo de ~30 dias. Proteger da luz. N\u00e3o congelar-descongelar a solu\u00e7\u00e3o reconstitu\u00edda.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u00c1gua bacteriost\u00e1tica (recomendada). Os tr\u00eas pept\u00eddeos reconstituem-se simultaneamente a partir do mesmo frasco; a solu\u00e7\u00e3o reconstitu\u00edda deve manter um tom azul claro devido ao Cu ligado<sup>2+<\/sup> de GHK-Cu.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>O que \u00e9 o GLOW?<\/h2>\n<p><strong>GLOW<\/strong> is a pharmaceutical-grade co-formulated three-peptide blend that combines <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a> (Body Protection Compound 157), <a href=\"https:\/\/medsbase.com\/pt-pt\/ghk-cu\/\">GHK-Cu<\/a> (Complexo de Cobre(II) Glicil-Histidil-Lisina), e <a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500\/\">TB-500<\/a> (Thymosin Beta-4 fragment) in a single lyophilized vial at a 1:5:1 mass ratio \u2014 10\u00a0mg BPC-157, 50\u00a0mg GHK-Cu, and 10\u00a0mg TB-500 per vial, for a total of 70\u00a0mg peptide mass. The three peptides represent three of the most cited regenerative-compounds in the published literature, each acting on a different molecular axis: BPC-157 on local angiogenesis and growth-factor signalling, GHK-Cu on copper-mediated dermal remodelling and antioxidant signalling, and TB-500 on systemic G-actin-binding and cell migration. The strategic rationale for the GLOW blend is <strong>mecanismos complementares e n\u00e3o sobrepostos<\/strong> across three regenerative axes. Each component peptide has a distinct molecular target and tissue-distribution pattern, so co-administration covers a broader range of studies endpoints than any single component alone. The blend is intended for studies that benefits from simultaneous activation of all three pathways \u2014 a use case distinct from studies designs that require independent dosing of each component peptide. For studies that needs <strong>dosagem independente<\/strong> de cada p\u00e9ptido (diferentes doses, diferentes esquemas, diferentes formula\u00e7\u00f5es de ve\u00edculo), os componentes tamb\u00e9m est\u00e3o dispon\u00edveis como frascos individuais: <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a>, <a href=\"https:\/\/medsbase.com\/pt-pt\/ghk-cu\/\">GHK-Cu<\/a>, e <a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500\/\">TB-500<\/a>. Um conjunto separado de tr\u00eas frascos \u2014 o <a href=\"https:\/\/medsbase.com\/pt-pt\/peptide-healing-stack\/\">Conjunto de Pept\u00eddeos para Cura<\/a> (BPC-157 + TB-500 + bacteriostatic water shipped together as three separate vials) \u2014 provides another alternative for studies requiring per-component dose-flexibility. The GLOW co-formulation is specifically for studies at the fixed 1:5:1 mass ratio with single-vial reconstitution. GLOW is supplied as a high-purity lyophilized blend for reconstitution with bacteriostatic water. The reconstituted solution retains a faint blue tint from the bound Cu<sup>2+<\/sup> do componente GHK-Cu \u2014 um indicador qualitativo \u00fatil de que a coordena\u00e7\u00e3o do cobre permaneceu intacta durante a liofiliza\u00e7\u00e3o e reconstitui\u00e7\u00e3o. O GLOW n\u00e3o \u00e9 <strong>aprovado<\/strong> by the FDA, EMA, MHRA, or any other major regulator for human therapeutic use as a combination or as any of its component peptides. <\/p>\n<h2>Mecanismo de A\u00e7\u00e3o \u2014 Tr\u00eas Vias Regenerativas Complementares<\/h2>\n<p>O que torna a coformula\u00e7\u00e3o GLOW farmacologicamente distinta \u00e9 o <strong>perfil de mecanismo triaxial<\/strong> \u2014 each component activates a fundamentally different regenerative pathway, and the three are non-overlapping at the molecular level. Published studies on each component has established the mechanism in detail; the combination simply delivers all three in a single administration:<\/p>\n<ul>\n<li><strong>BPC-157 (10 mg) \u2014 sinaliza\u00e7\u00e3o VEGF\/NO\/recetor de GH para repara\u00e7\u00e3o tecidual local<\/strong> \u2014 The 15-amino-acid pentadecapeptide derived from gastric juice upregulates VEGFR2 (driving new capillary formation at injury sites), enhances endothelial nitric oxide synthase activity (protecting vascular endothelium), and increases growth-hormone receptor expression on fibroblasts and tenocytes (driving collagen synthesis). Most-cited signal: tendon, ligament, gut barrier, and skeletal muscle recovery. Acts more locally than systemic at the injection site.<\/li>\n<li><strong>GHK-Cu (50 mg) \u2014 remodela\u00e7\u00e3o d\u00e9rmica mediada por cobre e sinaliza\u00e7\u00e3o antioxidante<\/strong> \u2014 O i\u00e3o Cu<sup>2+<\/sup>-coordinated tripeptide delivers copper as an enzyme cofactor for lysyl oxidase (collagen\/elastin cross-linking) and superoxide dismutase (oxidative-stress buffering) while signalling on dermal fibroblasts and keratinocytes. Most-cited signal: skin remodelling, wound healing, anti-aging in connective-tissue studies, hair follicle support, copper-axis pharmacology. Higher mass loading (50\u00a0mg in the blend) reflects the larger doses typical of copper-peptide studies vs the microgram-range doses of the other two components.<\/li>\n<li><strong>TB-500 (10 mg) \u2014 sequestro de G-actina e migra\u00e7\u00e3o celular sist\u00e9mica<\/strong> \u2014 The 43-amino-acid thymic peptide is the canonical systemic regenerative compound, binding monomeric G-actin and modulating actin dynamics to drive cell migration, particularly at injury sites. Most-cited signal: systemic muscle and cardiac recovery, vascular repair, and broad systemic distribution that complements BPC-157&#8217;s more localised action. Acts as the &#8220;systemic arm&#8221; to BPC-157&#8217;s &#8220;local arm&#8221;.<\/li>\n<\/ul>\n<p>Os tr\u00eas percursos s\u00e3o <strong>mecanicamente complementares<\/strong>, not redundant: BPC-157 acts locally on the injury site, TB-500 distributes systemically and supports cell migration globally, and GHK-Cu provides copper-cofactor delivery and dermal-tissue-specific signalling. Co-administering the three in study models covers angiogenesis (BPC-157), systemic recovery (TB-500), and dermal-tissue remodelling (GHK-Cu) simultaneously \u2014 a broader studies endpoint coverage than any single component alone. All three peptides have well-tolerated profiles in published preclinical studies, and combination protocols are described in some published studies models of multi-axis tissue regeneration. <\/p>\n<h2>Published Evidence<\/h2>\n<p>GLOW co-formulation is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Multi-axis tissue regeneration<\/strong> \u2014 preclinical models combining systemic and local regenerative endpoints; angiogenesis + cell migration + dermal remodelling in single studies designs<\/li>\n<li><strong>Wound healing studies<\/strong> \u2014 modelos de feridas cut\u00e2neas (espessura total, espessura parcial, queimaduras), cin\u00e9tica de contra\u00e7\u00e3o de feridas, forma\u00e7\u00e3o de tecido de granula\u00e7\u00e3o, caracteriza\u00e7\u00e3o de tecido cicatricial; uma das abordagens multi-eixo mais abrangentes<\/li>\n<li><strong>Recupera\u00e7\u00e3o de tend\u00f5es, ligamentos e tecidos moles<\/strong> \u2014 rodent Achilles transection models, medial-collateral-ligament rupture studies; published BPC-157 + TB-500 literature is extensive, with the GHK-Cu addition providing copper-cofactor support for collagen cross-linking<\/li>\n<li><strong>Skin remodelling and dermal studies<\/strong> \u2014 collagen and elastin synthesis, dermal-fibroblast proliferation, photo-aging studies; the GHK-Cu component dominates this studies domain<\/li>\n<li><strong>Comparative co-formulation studies<\/strong> \u2014 frente a frente com <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a>, <a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500\/\">TB-500<\/a>, e <a href=\"https:\/\/medsbase.com\/pt-pt\/ghk-cu\/\">GHK-Cu<\/a> bra\u00e7os; disseca\u00e7\u00e3o dos efeitos aditivos versus sin\u00e9rgicos na combina\u00e7\u00e3o de tr\u00eas eixos<\/li>\n<li><strong>Vascular and cardiac recovery<\/strong> \u2014 o sinal angiog\u00e9nico combinado (BPC-157) e migrat\u00f3rio (TB-500) \u00e9 bem adequado para modelos de recupera\u00e7\u00e3o vascular e isquemia card\u00edaca<\/li>\n<li><strong>Anti-aging and longevity studies<\/strong> \u2014 published work on copper-peptide effects in dermal and connective-tissue aging, particularly relevant for the GHK-Cu component; combined with BPC-157 + TB-500 for broader tissue-aging studies designs<\/li>\n<li><strong>Inflammation and oxidative-stress studies<\/strong> \u2014 copper&#8217;s role as cofactor for superoxide dismutase plus the BPC-157 and TB-500 inflammation-modulating effects provide multi-axis anti-inflammatory studies coverage.<\/li>\n<\/ul>\n<p>Para um contexto mais amplo, consulte as nossas p\u00e1ginas <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a>, <a href=\"https:\/\/medsbase.com\/pt-pt\/ghk-cu\/\">GHK-Cu<\/a>, e <a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500\/\">TB-500<\/a> p\u00e1ginas de produto para farmacologia ao n\u00edvel dos componentes, o <a href=\"https:\/\/medsbase.com\/pt-pt\/peptide-healing-stack\/\">Conjunto de Pept\u00eddeos para Cura<\/a> para o pacote alternativo de tr\u00eas frascos separados (BPC-157 + TB-500 + \u00e1gua bacteriost\u00e1tica), e o pept\u00eddeo de cobre irm\u00e3o <a href=\"https:\/\/medsbase.com\/pt-pt\/ahk-cu\/\">AHK-Cu<\/a> for hair-axis studies. Browse the full <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\">cat\u00e1logo de p\u00e9ptidos<\/a> para encontrar compostos relacionados. <\/p>\n<h2>Configura\u00e7\u00f5es Dispon\u00edveis<\/h2>\n<p>A MedsBase tem dispon\u00edvel a mistura GLOW numa \u00fanica coformula\u00e7\u00e3o: <strong>10 mg de BPC-157 + 50 mg de GHK-Cu + 10 mg de TB-500 por frasco<\/strong> (propor\u00e7\u00e3o de massa 1:5:1, 70 mg de pept\u00eddeos no total). O frasco est\u00e1 dispon\u00edvel em embalagens de 10 ou 20 frascos com instru\u00e7\u00f5es completas de reconstitui\u00e7\u00e3o:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Composi\u00e7\u00e3o do Frasco<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso de uso t\u00edpico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Tamanhos das embalagens<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg de BPC-157 + 50 mg de GHK-Cu + 10 mg de TB-500<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard tri-axis regenerative-studies blend \u2014 angiogenesis + dermal remodelling + systemic cell migration in single administration<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10 ou 20 frascos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three components are supplied at \u226599% HPLC purity (each verified individually) and pre-mixed in the same lyophilized vial. Because the three peptides have different dose ranges and different roles in the blend, the 1:5:1 mass ratio is fixed at manufacture. Users requiring different ratios should use the stand-alone <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a>, <a href=\"https:\/\/medsbase.com\/pt-pt\/ghk-cu\/\">GHK-Cu<\/a>, e <a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500\/\">TB-500<\/a> vials instead. Compared with purchasing the three components separately, the GLOW co-formulation offers a meaningful cost saving and the practical convenience of single-vial reconstitution at the fixed studies ratio. <\/p>\n<h2>Como Comparar \u2014 Mistura GLOW vs Conjunto de Pept\u00eddeos de Cura<\/h2>\n<p>MedsBase carries two multi-peptide studies products that combine the same broader healing-peptide pharmacology in different packaging formats. The choice between them depends on studies design requirements:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Crit\u00e9rio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Mistura GLOW<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\"><a href=\"https:\/\/medsbase.com\/pt-pt\/peptide-healing-stack\/\">Conjunto de Pept\u00eddeos para Cura<\/a><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Formato de embalagem<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Frasco \u00fanico, coformulado<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tr\u00eas frascos separados enviados em conjunto<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Composi\u00e7\u00e3o<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">BPC-157 10 mg + GHK-Cu 50 mg + TB-500 10 mg<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">BPC-157 5 mg + TB-500 5 mg + \u00c1gua Bacteriost\u00e1tica<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>N\u00famero de componentes<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Tr\u00eas pept\u00eddeos (inclui pept\u00eddeo de cobre)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Dois pept\u00eddeos + diluente (sem pept\u00eddeo de cobre)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Flexibilidade de dosagem<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Propor\u00e7\u00e3o de massa fixa 1:5:1 por frasco<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Dose independente por componente<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Reconstitui\u00e7\u00e3o<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u00danico evento de reconstitui\u00e7\u00e3o<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Reconstitui\u00e7\u00e3o por frasco<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Caso de utiliza\u00e7\u00e3o<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Convenience + fixed-ratio studies; broader 3-axis coverage including dermal remodelling<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Dose-flexible studies; classic 2-axis healing focus (BPC + TB only)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Studies designs that require flexible per-component dosing or that don&#8217;t need the copper-peptide arm should use the <a href=\"https:\/\/medsbase.com\/pt-pt\/peptide-healing-stack\/\">Conjunto de Pept\u00eddeos para Cura<\/a>. Studies designs that benefit from the broader three-axis coverage (including dermal-tissue remodelling) and that are comfortable with the fixed 1:5:1 mass ratio should use the GLOW blend. Both options are pre-curated for the most-cited healing-peptide studies pharmacology \u2014 the difference is packaging format and component breadth. <\/p>\n<h2>Armazenamento e Reconstitui\u00e7\u00e3o<\/h2>\n<p><strong>Antes da reconstitui\u00e7\u00e3o:<\/strong> armazenar os frascos liofilizados refrigerados a 2\u20138 \u00b0C na embalagem original para stock de trabalho a curto prazo. Para armazenamento a longo prazo sem abertura, congelar a \u221220 \u00b0C. A coformula\u00e7\u00e3o GLOW liofilizada \u00e9 est\u00e1vel sob refrigera\u00e7\u00e3o por at\u00e9 24 meses e a \u221220 \u00b0C por at\u00e9 36 meses. Todos os tr\u00eas pept\u00eddeos componentes apresentam perfis de estabilidade bem compat\u00edveis no estado liofilizado. Evitar ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o no p\u00f3 liofilizado. <strong>Procedimento de reconstitui\u00e7\u00e3o:<\/strong> injetar \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco (n\u00e3o diretamente sobre o comprimido liofilizado). Como o frasco cont\u00e9m 70 mg de massa total de pept\u00eddeo, uma reconstitui\u00e7\u00e3o de 2,0 mL produz uma concentra\u00e7\u00e3o de trabalho de pept\u00eddeo total de 35 mg\/mL \u2014 equivalente a 5 mg\/mL de BPC-157, 25 mg\/mL de GHK-Cu e 5 mg\/mL de TB-500. Agitar suavemente \u2014 n\u00e3o <strong>n\u00e3o<\/strong> agite \u2014 e aguarde 2\u20135 minutos para dissolu\u00e7\u00e3o completa. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda deve estar l\u00edmpida com um <strong>tom azul claro<\/strong> do Cu ligado<sup>2+<\/sup> do componente GHK-Cu \u2014 a cor \u00e9 um indicador qualitativo \u00fatil de que a coordena\u00e7\u00e3o do cobre permaneceu intacta durante a liofiliza\u00e7\u00e3o e reconstitui\u00e7\u00e3o. Turbidez, precipitado ou aus\u00eancia do tom azul indicam um problema; descarte e tente novamente. <strong>Ap\u00f3s reconstitui\u00e7\u00e3o:<\/strong> armazene refrigerado a 2\u20138 \u00b0C e utilize no prazo de 30 dias para uma estabilidade \u00f3tima dos tr\u00eas componentes. N\u00e3o congele a solu\u00e7\u00e3o reconstitu\u00edda \u2014 ciclos de congela\u00e7\u00e3o e descongela\u00e7\u00e3o degradam a integridade do p\u00e9ptido e podem afetar a coordena\u00e7\u00e3o do cobre. Proteja sempre da luz direta. Descarte qualquer frasco que apresente turbidez, precipitado ou descolora\u00e7\u00e3o al\u00e9m do tom azul claro esperado. <\/p>\n<h2 id=\"faqs\">Perguntas Frequentes<\/h2>\n<h3>What is GLOW used for in studies?<\/h3>\n<p>GLOW is used in studies investigating multi-axis tissue regeneration \u2014 specifically protocols that benefit from simultaneous activation of three complementary regenerative pathways (BPC-157 angiogenesis + GHK-Cu dermal remodelling + TB-500 systemic cell migration) in a single administration. Common contexts include wound healing models, tendon and soft-tissue recovery, skin remodelling, vascular repair, anti-aging connective-tissue studies, and comparative co-formulation pharmacology. The pharmaceutical-grade GLOW sold here is <strong>n\u00e3o<\/strong> FDA-approved and is supplied strictly for clinical studies use only. <\/p>\n<h3>O que cont\u00e9m um frasco de GLOW?<\/h3>\n<p>Cada frasco cont\u00e9m <strong>10 mg de BPC-157, 50 mg de GHK-Cu e 10 mg de TB-500<\/strong>, co-formulated and lyophilized together as a single powder. Total peptide mass per vial: 70\u00a0mg. The 1:5:1 mass ratio reflects the different studies-relevant dose ranges of the three components (BPC-157 and TB-500 are used in microgram-to-low-milligram doses; GHK-Cu is used in low-to-mid-milligram doses). All three peptides reconstitute simultaneously when bacteriostatic water is added. <\/p>\n<h3>Em que \u00e9 que o GLOW difere do Peptide Healing Stack?<\/h3>\n<p>Os dois produtos combinam p\u00e9ptidos de cura relacionados, mas em formatos de embalagem diferentes. <strong>GLOW<\/strong> \u00e9 um \u00fanico frasco com tr\u00eas p\u00e9ptidos (BPC-157 + GHK-Cu + TB-500) coformulados numa propor\u00e7\u00e3o fixa de 1:5:1. O <a href=\"https:\/\/medsbase.com\/pt-pt\/peptide-healing-stack\/\">Conjunto de Pept\u00eddeos para Cura<\/a> is three separate vials (BPC-157 + TB-500 + bacteriostatic water) shipped in one parcel. GLOW adds the copper-peptide arm and consolidates reconstitution; the Peptide Healing Stack offers per-component dose independence without the copper-peptide component. Choose based on whether your studies needs the dermal-remodelling axis (GLOW) or per-component dose flexibility (Peptide Healing Stack). <\/p>\n<h3>Em que \u00e9 que o GLOW difere dos p\u00e9ptidos componentes individuais?<\/h3>\n<p>Os componentes tamb\u00e9m est\u00e3o dispon\u00edveis como produtos individuais: <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a>, <a href=\"https:\/\/medsbase.com\/pt-pt\/ghk-cu\/\">GHK-Cu<\/a>, e <a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500\/\">TB-500<\/a>. Os frascos individuais permitem o controlo da dose por componente, hor\u00e1rios diferentes por p\u00e9ptido e formula\u00e7\u00f5es de ve\u00edculo diferentes por p\u00e9ptido. A coformula\u00e7\u00e3o GLOW fixa a propor\u00e7\u00e3o da dose em 1:5:1 em massa, mas oferece conveni\u00eancia (reconstitui\u00e7\u00e3o \u00fanica, inje\u00e7\u00e3o \u00fanica) e poupan\u00e7a de custos moderada em compara\u00e7\u00e3o com a compra dos tr\u00eas componentes separadamente. <\/p>\n<h3>What is the typical GLOW dose?<\/h3>\n<p>Dose depends on the studies endpoint. Conservative protocols use 0.04\u00a0mL of a 35\u00a0mg\/mL reconstituted solution (~200\u00a0mcg BPC-157 + 1\u00a0mg GHK-Cu + 200\u00a0mcg TB-500 per administration) several times weekly. Higher-dose protocols scale up proportionally within the fixed 1:5:1 ratio. Users requiring different ratios should use the stand-alone components rather than the blend. <\/p>\n<h3>O GLOW \u00e9 aprovado pela FDA?<\/h3>\n<p>No. GLOW is not approved by the FDA, EMA, MHRA, or any other major regulator as a combination product. None of the three individual components (BPC-157, GHK-Cu, TB-500) have FDA approval for human therapeutic use either. GHK-Cu is incorporated into some cosmetic products under cosmetic-regulation frameworks, but none of the three peptides is approved as a drug. <\/p>\n<h3>Por que \u00e9 que a solu\u00e7\u00e3o GLOW tem um tom azulado?<\/h3>\n<p>O tom azulado fraco prov\u00e9m do Cu ligado<sup>2+<\/sup> do componente GHK-Cu \u2014 especificamente das transi\u00e7\u00f5es eletr\u00f3nicas d-d do cobre no ambiente de coordena\u00e7\u00e3o quadrado-planar criado pelo tripept\u00eddeo Gly-His-Lys. A cor \u00e9 um indicador qualitativo \u00fatil da coordena\u00e7\u00e3o intacta do cobre: uma solu\u00e7\u00e3o GLOW devidamente reconstitu\u00edda deve apresentar um tom azulado vis\u00edvel fraco; uma solu\u00e7\u00e3o incolor ou p\u00e1lida sugeriria perda de cobre ou degrada\u00e7\u00e3o do componente GHK-Cu. Os outros dois p\u00e9ptidos (BPC-157, TB-500) n\u00e3o contribuem para a cor. <\/p>\n<h3>Como deve ser armazenado o GLOW?<\/h3>\n<p>Frascos liofilizados: refrigerados a 2\u20138 \u00b0C para stock de trabalho a curto prazo, ou \u221220 \u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. Solu\u00e7\u00e3o reconstitu\u00edda: refrigerada a 2\u20138 \u00b0C, utilizar no prazo de 30 dias. N\u00e3o congelar a solu\u00e7\u00e3o reconstitu\u00edda \u2014 os ciclos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o degradam a integridade do p\u00e9ptido e podem afetar desproporcionalmente a coordena\u00e7\u00e3o do cobre ou a estabilidade da estrutura do p\u00e9ptido. Proteger sempre da luz direta. <\/p>\n<h3>Como reconstituo o GLOW?<\/h3>\n<p>Siga o procedimento de reconstitui\u00e7\u00e3o acima. Adicione \u00e1gua bacteriost\u00e1tica pela parede lateral do frasco (n\u00e3o diretamente sobre o p\u00f3 liofilizado), agite suavemente e aguarde 2 a 5 minutos para dissolu\u00e7\u00e3o completa. N\u00e3o <strong>n\u00e3o<\/strong> Agitar o frasco. Os tr\u00eas p\u00e9ptidos reconstituem-se simultaneamente a partir do mesmo frasco. Uma solu\u00e7\u00e3o corretamente reconstitu\u00edda \u00e9 transparente com um ligeiro tom azul. Para um frasco + 2,0 mL de diluente, a concentra\u00e7\u00e3o de trabalho \u00e9 de 5 mg\/mL de BPC-157, 25 mg\/mL de GHK-Cu e 5 mg\/mL de TB-500. <\/p>\n<h3>Que configura\u00e7\u00f5es tem a MedsBase em stock?<\/h3>\n<p>A MedsBase disponibiliza o GLOW numa \u00fanica coformula\u00e7\u00e3o: 10 mg de BPC-157 + 50 mg de GHK-Cu + 10 mg de TB-500 por frasco (70 mg de p\u00e9ptido total, propor\u00e7\u00e3o de massa 1:5:1, liofilizado). O frasco est\u00e1 dispon\u00edvel em embalagens de 10 ou 20 frascos. Cada componente \u00e9 verificado individualmente com uma pureza \u226599% por HPLC, com um certificado de an\u00e1lise dispon\u00edvel mediante pedido. <\/p>\n<h3>Posso comprar os componentes do GLOW separadamente?<\/h3>\n<p>Sim \u2014 a MedsBase tem os tr\u00eas p\u00e9ptidos componentes dispon\u00edveis como produtos individuais: <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a> em frascos de 2\/5\/10 mg, <a href=\"https:\/\/medsbase.com\/pt-pt\/ghk-cu\/\">GHK-Cu<\/a>, e <a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500\/\">TB-500<\/a> in 2\/5\/10\u00a0mg vials. Separate vials are useful if protocols require dose ratios other than the fixed 1:5:1 GLOW ratio, or if users want different scheduling per peptide. The co-formulated GLOW blend offers convenience and cost savings for studies at the 1:5:1 ratio. <\/p>\n<h3>Does GLOW cause side reported effects?<\/h3>\n<p>All three component peptides have well-tolerated profiles in published preclinical studies at typical doses. The most consistent finding for the combination is the same as for the individual components: local injection-site reactions, occasional flushing at higher doses, and (rarely) modest skin discolouration at the injection site from copper deposition (from the GHK-Cu component). Systemic adverse effects are uncommon in published preclinical literature for any of the three peptides. <\/p>\n<h3>How long does GLOW take to show effects in preclinical studies?<\/h3>\n<p>Effect onset varies by studies endpoint. Local wound-healing and tissue-recovery effects are typically measurable within 7\u201314 days of regular dosing. Skin-remodelling effects (collagen synthesis, dermal-fibroblast activity) accumulate over 4\u20138 weeks. Systemic regenerative effects mediated by TB-500 develop over similar timescales. The combined three-axis profile produces a broader endpoint coverage than any single component, but the kinetics for each axis follow the timeline of the respective component peptide. <\/p>\n<h3>Posso encomendar o GLOW para envio internacional?<\/h3>\n<p>Sim. A MedsBase envia o GLOW para todo o mundo a partir da nossa rede dedicada de envio de p\u00e9ptidos. Encomendas apenas de p\u00e9ptidos qualificam-se para o nosso servi\u00e7o de envio de p\u00e9ptidos independente. Todas as encomendas s\u00e3o enviadas em embalagens com controlo de temperatura, com rastreio completo e cobertas pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\">Pol\u00edtica de Garantia de Reenvio<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Tissue Regeneration, Wound Healing, and Recovery Studies<\/h2>\n<ul>\n<li><a href=\"\/pt-pt\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Composto de Prote\u00e7\u00e3o Corporal \u2014 o componente de angiog\u00e9nese local do GLOW, frascos individuais<\/li>\n<li><a href=\"\/pt-pt\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Tripept\u00eddeo de cobre \u2014 o componente de remodela\u00e7\u00e3o d\u00e9rmica do GLOW, frascos individuais<\/li>\n<li><a href=\"\/pt-pt\/tb-500\/\"><strong>TB-500 (Thymosin Beta-4)<\/strong><\/a> \u2014 Fragmento de cura sist\u00e9mica \u2014 o componente de migra\u00e7\u00e3o celular sist\u00e9mica do GLOW<\/li>\n<li><a href=\"\/pt-pt\/peptide-healing-stack\/\"><strong>Conjunto de Pept\u00eddeos para Cura<\/strong><\/a> \u2014 Pacote alternativo de tr\u00eas frascos (BPC + TB + \u00e1gua BAC) sem pept\u00eddeo de cobre<\/li>\n<li><a href=\"\/pt-pt\/ahk-cu\/\"><strong>AHK-Cu<\/strong><\/a> \u2014 Sister copper peptide to GHK-Cu \u2014 hair follicle compound<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Leitura Adicional<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore the regenerative-peptide studies landscape<\/strong><\/p>\n<p style=\"margin: 0;\">Explore a gama completa <a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\"><strong>cat\u00e1logo de p\u00e9ptidos<\/strong><\/a>, com compostos regenerativos relacionados incluindo <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157\/\">BPC-157<\/a> (angiog\u00e9nese local), <a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500\/\">TB-500<\/a> (migra\u00e7\u00e3o celular sist\u00e9mica), <a href=\"https:\/\/medsbase.com\/pt-pt\/ghk-cu\/\">GHK-Cu<\/a> (remodela\u00e7\u00e3o d\u00e9rmica), e a alternativa <a href=\"https:\/\/medsbase.com\/pt-pt\/peptide-healing-stack\/\">Conjunto de Pept\u00eddeos para Cura<\/a> bundle.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Mistura regenerativa coformulada com tr\u00eas pept\u00eddeos<br \/>\n\u2705 BPC-157 (10mg) + GHK-Cu (50mg) + TB-500 (10mg)<br \/>\n\u2705 Angiog\u00e9nese local + remodela\u00e7\u00e3o d\u00e9rmica + migra\u00e7\u00e3o celular sist\u00e9mica<br \/>\n\u2705 Frasco \u00fanico, reconstitui\u00e7\u00e3o \u00fanica<br \/>\n\u2705 70mg de pept\u00eddeo total por frasco<\/p>\n<p><strong>GLOW<\/strong> \u00e9 uma mistura coformulada de pept\u00eddeos.<\/p>","protected":false},"featured_media":70957,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5440,5449,6291,5441,5442],"class_list":["post-70799","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-bpc-157","product_tag-ghk-cu","product_tag-glow","product_tag-peptide","product_tag-tb-500","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product\/70799","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=70799"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media\/70957"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=70799"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_brand?post=70799"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_cat?post=70799"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_tag?post=70799"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}